Zobrazeno 1 - 10
of 109
pro vyhledávání: '"A G, Dorfman"'
Autor:
O. V. Nikitina, I. P. Mikhailov, N. Y. Kudryashova, E. V. Migunova, A. G. Dorfman, V. I. Avfukov
Publikováno v:
Неотложная медицинская помощь, Vol 7, Iss 3, Pp 209-216 (2018)
Background The advantage of thrombolytic therapy (TLT) over anticoagulant therapy(ACT) in patients with a high risk of early death (hemodynamic disorders) in acute pulmonary embolism is considered proven. But the advantage of thrombolytic therapy ove
Externí odkaz:
https://doaj.org/article/df77140cf5be40588e190403e147bfde
Autor:
Yang Li, Mingming Zhang, Robert G. Dorfman, Yida Pan, Dehua Tang, Lei Xu, Zhenguo Zhao, Qian Zhou, Lixing Zhou, Yuming Wang, Yuyao Yin, Shanshan Shen, Bo Kong, Helmut Friess, Shimin Zhao, Lei Wang, Xiaoping Zou
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 20, Iss 7, Pp 745-756 (2018)
Metastasis is the most important feature of gastric cancer (GC) and the most widely recognized reason for GC-related deaths. Unfortunately, the underlying mechanism behind this metastasis remains unknown. Mounting evidence suggests the dynamic regula
Externí odkaz:
https://doaj.org/article/76137a19627a44b597c20cea60e219f5
Publikováno v:
Plastic & Reconstructive Surgery. 151:748e-757e
Autor:
Mingming Zhang, Yida Pan, Robert G. Dorfman, Yuyao Yin, Qian Zhou, Shan Huang, Jie Liu, Shimin Zhao
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
Abstract Phosphoenolpyruvate carboxykinase 1 (PEPCK1) is the critical enzyme for gluconeogenesis and is linked with type II diabetes. Previous studies have found that SIRT2, a deacetylase, plays an important role in deacetylating PEPCK1 and little is
Externí odkaz:
https://doaj.org/article/ed6b75e32b7c475a94c7c22d11ce7103
Publikováno v:
Неотложная медицинская помощь, Vol 0, Iss 2, Pp 54-57 (2016)
Analysing 166 cases of patients operated on in 2007 – 2013, we revealed adverse factors of postoperative period, leading to serious complications and death. The developed comprehensive approach allows to improve treatment outcomes in patients with
Externí odkaz:
https://doaj.org/article/abb0a13d6ab947fe8ed3b5537ca44521
Autor:
M. Sh. Khubutia, A. K. Shabanov, G. V. Bulava, A. G. Dorfman, Z. M. Zainudinov, M. V. Skulachev, A. N. Kuzovlev, O. A. Grebenchikov, A. A. Sergeev, M. I. Shpitonkov, G. Yu. Maltsev
Publikováno v:
Общая реаниматология, Vol 10, Iss 2, Pp 23-30 (2014)
Polytrauma is a serious threat to human life not only due to its direct damage to vital organs, but also to the development of significant oxidative distress that gives rise to multiple organ dysfunction. At the same time, the risk of lifethreatening
Externí odkaz:
https://doaj.org/article/54f6b586ecd64ee28b38a4f97ee573b2
Publikováno v:
Annals of the Royal College of Surgeons of England. 104(4)
Neuroendocrine neoplasms represent a broad group of uncommon tumours, comprising neuroendocrine tumours, mixed neuroendocrine non-endocrine neoplasms and neuroendocrine carcinomas. While most neuroendocrine neoplasms are well differentiated and exhib
Autor:
Lei Wang, Robert G. Dorfman, Yang Li, Chenfei Jiang, Rui Cai, Lixing Zhou, Yuming Wang, Dehua Tang, Lei Xu, Xiaoping Zou, Li Liu, Mingming Zhang
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 5, Pp 2380-2391 (2019)
Cancer Medicine, Vol 8, Iss 5, Pp 2380-2391 (2019)
Cholangiocarcinoma (CCA) is an extremely invasive malignancy with late diagnosis and unfavorable prognosis. Surgery and chemotherapy are still not effective in improving outcomes in CCA patients. It is crucial to explore a novel therapeutic target fo
Publikováno v:
Plastic and Reconstructive Surgery. 143:734-742
Autor:
Dehua Tang, Yida Pan, Lixing Zhou, Chengfei Jiang, Lei Xu, Robert G. Dorfman, Mingming Zhang, Yuyao Yin, Xiaoping Zou, Lei Wang, Jian-lin Wu, Yuming Wang
Publikováno v:
Neoplasia (New York, N.Y.)
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 5, Pp 429-441 (2019)
Neoplasia: An International Journal for Oncology Research, Vol 21, Iss 5, Pp 429-441 (2019)
Cholangiocarcinoma (CCA) is a malignant cancer with an unknown etiology and an unfavorable prognosis. Most patients are diagnosed at an advanced stage, thus making it essential to find novel curative targets for CCA. Metabolic reprogramming of the tu